Amy Carroll

Are CVs the answer to GP stakes exit challenges?

GP-led secondaries would appear to provide an obvious route to liquidity for staking investors but there are some issues to iron out.

Can due diligence make private equity a better boss?

GPs are increasingly scrutinising target companies’ workplace practices in an effort to invest responsibly, satisfy LP demands and reap the financial rewards.

Technology lends a helping hand with GP stakes investing

The sheer volume of management company, fund and portfolio-level data involved in GP stakes investing means the asset class is ripe for an AI revolution.

Moving beyond the AI hype to create real value

With MIT research revealing that just 5% of artificial intelligence initiatives succeed, how can private markets firms ensure their AI efforts will lead to genuine value creation?

AI’s effect on the nuts and bolts of private markets operations

Artificial intelligence has the potential to revolutionise the investment lifecycle, but there will be challenges along the way.

The rise and rise of take-privates

Short-term and increasingly passive public markets aren’t always the right fit for major transformations, particularly those being driven by trends such as decarbonisation and AI.

Modelling public-private exposure

Do customisable models incorporating both public and private markets exposure represent the next step in the democratisation of alternatives?

Restoring the balance between public and private markets

Companies are staying private for longer, but our economies need fully functioning and vibrant public markets as well.

Roundtable: Breaking the mid-market deadlock

Although European mid-market M&A remains muted, creative dealmaking in select sectors is beginning to unclog the system.

Alternatives managers change tack on ESG comms

As anti-ESG rhetoric in the US intensifies, private markets players appear to be dialling down their messaging, but not their actions.